---
$id: https://graph.org.ai/products/commodity/51343304
$type: Product
source: UNSPSC
code: "51343304"
title: "Mozenavir"
class: "51343300"
classTitle: "Antivirals, synthesized"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mozenavir

**UNSPSC Code**: 51343304
**Class**: [Antivirals, synthesized](Antivirals, synthesized.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protease inhibitor with the molecular formula C33H36N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64OO8946ER. The term MOZENAVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46. ). Most nations schedule mozenavir under HS 29339940 and SITC 51577. As of Q4 2014, MOZENAVIR remains the US FDA Preferred Term for this commodity. Mozenavir bears US NLM identifiers UMLS ID C0390428 and NCI Concept Code C77390. SMILES: C1=CC=C(C=C1)CC2C(C(C(N(C(=O)N2CC3=CC(=CC=C3)N)CC4=CC(=CC=C4)N)CC5=CC=CC=C5)O)O.

